No Picture
News

Regulus Therapeutics’ Director David Baltimore Receives 2021 Lasker-Koshland Special Achievement Award in Medical Science

SAN DIEGO: SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that […]

No Picture
News

Promising New OpRegen® Clinical Data Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, reported today that updated interim results from a Phase 1/2a […]

No Picture
News

Biologica Technologies® announces the presentation of ProteiOS® clinical data at the North American Spine Society 36th Annual Meeting in Boston

CARLSBAD, Calif.: CARLSBAD, Calif., Sept. 30, 2021 /PRNewswire/ — Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced today the podium presentation, ‘Retrospective assessment of radiographic outcomes after implantation […]

No Picture
Los Angeles Biotech Trending News

Dermavant Showcases New Long-Term Data from Phase 3 PSOARING 3 Trial of Tapinarof in Patients with Plaque Psoriasis at the 30th EADV Virtual Congress

LONG BEACH, Calif., & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant Showcases New Long-Term Data from Phase 3 PSOARING 3 Trial of Tapinarof in Patients with Plaque Psoriasis at the 30th EADV Virtual Congress Click to view original post

No Picture
News

Illumina Expands Presence in Latin America

SAN DIEGO: SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced the creation of Illumina Colombia S.A.S. and Illumina México Productos de Biotecnología marking our commitment to expand genomics in Latin America […]